H.C. Wainwright Reiterates Buy Rating on Plus Therapeutics Inc. (PSTV)
Tweet Send to a Friend
H.C. Wainwright analyst Sean Lee reiterated a Buy rating and $2.00 price target on Plus Therapeutics Inc. (NASDAQ: PSTV).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


